Each year, 42,000 women In the United States are diagnosed with uterine cancer, the most common malignancy of the female genital tract and the fourth most common cancer in women.

Uterine cancer forms in tissues of the uterus and can appear in cells lining the uterus (endometrium) and in muscle or other tissues in the uterus (uterine sarcoma).

While there are a range of non-invasive treatment options to relieve symptoms of benign conditions or to slow the growth of gynecologic cancers, surgery remains the accepted and most effective treatment option for a range of gynecologic conditions.

Fortunately, minimally invasive robotic surgical options can effectively treat gynecological conditions and help overcome the limitations of traditional open surgery and a large incision. Robotic-assisted surgery can be used to perform a hysterectomy, one of the treatment options for uterine cancer.

Inova's state-of-the-art da Vinci® surgical system provides your doctor with enhanced vision, dexterity, control and precision as the surgery is performed through a few tiny incisions.

Benefits of robotic assisted surgery over open surgery include: